Pfizer Asks UK Regulator To Approve Vaccine For Teenagers

Pfizer Inc has submitted data on its Covid-19 vaccine among 12 to 15-year-olds to Britain's health regulator, a company spokesman said on Tuesday, paving the way for its authorisation to inoculate children in the country."I can confirm we've submitted data on the efficacy of the vaccine in 12 to 15 years olds for review by U.K. MHRA," the spokesman told Reuters by email. The move comes a day after U.S. regulators authorised the vaccine made by Pfizer and BioNTech SE for use in children as young as 12.In March, Pfizer and BioNTech said their Covid-19 vaccine was safe, effective and produced robust antibody responses in 12- to 15-year olds, citing a trial of 2,260 adolescents, which resulted in 100% efficacy in preventing the illness. Pfizer has said it expects to have safety and efficacy data on the vaccine for children aged 2 to 11 in September when it plans to ask for that age group to be included in the emergency authorisation.The Telegraph earlier reported that Pfizer had asked Britain's Medicines and Healthcare products Regulatory Agency for approval of the vaccine

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!